Dioscin
Dioscin is a steroidal saponin primarily extracted from Dioscorea species that demonstrates cardiovascular protective and anti-cancer properties. This compound works through multiple pathways including apoptosis induction and inflammatory modulation.

Origin & History
Dioscin is a steroidal saponin primarily sourced from Dioscorea plants such as Dioscorea nipponica and Dioscorea zingiberensis. It is extracted using solvent-based methods from rhizomes or tubers, followed by purification to isolate the compound.
Historical & Cultural Context
Dioscin-rich plants have been used in Traditional Chinese Medicine for cardiovascular diseases, inflammation, and pain. Dioscorea nipponica has been documented for over 1,000 years for treating rheumatism and pain.
Health Benefits
• May support cardiovascular health as seen in Di-Ao-Xin-Xue-Kang capsules used for over 20 years in China. [Quality: Traditional] • Potential anti-cancer properties through apoptosis induction and multidrug resistance inhibition in preclinical studies. [Quality: Preliminary] • Could have hepatoprotective effects as reported in preclinical studies, despite high-dose toxicity in mice. [Quality: Preliminary] • Might regulate glucose and lipid metabolism, beneficial for diabetes management, based on preclinical evidence. [Quality: Preliminary] • May offer cerebral protection by inhibiting specific inflammatory pathways, according to animal studies. [Quality: Preliminary]
How It Works
Dioscin activates intrinsic and extrinsic apoptotic pathways by upregulating p53 and Bax proteins while downregulating Bcl-2 expression in cancer cells. The compound inhibits NF-κB signaling and reduces inflammatory cytokines like TNF-α and IL-6. Additionally, dioscin modulates P-glycoprotein expression to overcome multidrug resistance in cancer cells.
Scientific Research
The clinical evidence for dioscin remains limited, with most studies being preclinical. DA-9801, a dioscin-containing product, completed a phase II RCT for diabetic neuropathy in the US, demonstrating safety but without detailed efficacy outcomes. Di-Ao-Xin-Xue-Kang capsules are approved in the Netherlands for cardiovascular use, yet without specific trial data.
Clinical Summary
Clinical evidence for dioscin primarily comes from traditional use in Di-Ao-Xin-Xue-Kang capsules for cardiovascular conditions over 20 years in China, though specific controlled trial data is limited. Preclinical studies show promising anti-cancer effects with IC50 values ranging from 10-50 μM in various cancer cell lines. Most research consists of in vitro and animal studies, with human clinical trials still needed to establish therapeutic dosages and efficacy. Current evidence quality ranges from traditional use patterns to preliminary laboratory investigations.
Nutritional Profile
Dioscin is a steroidal saponin (furostanol glycoside) with the molecular formula C₄₅H₇₂O₁₆ and molecular weight ~869.05 g/mol. It is not a nutritional compound per se but rather a bioactive phytochemical found in various plant sources. Key details: • **Chemical class:** Spirostanol saponin glycoside; aglycone is diosgenin, with a trisaccharide chain (rhamnose-rhamnose-glucose) attached at the C-3 position. • **Primary natural sources:** Rhizomes of Dioscorea species (wild yam, particularly D. nipponica and D. zingiberensis), also found in Trigonella foenum-graecum (fenugreek), Paris polyphylla, and Smilax china. Concentrations in Dioscorea rhizomes typically range from ~0.5–3.0% dry weight depending on species and growing conditions. • **Bioavailability:** Oral bioavailability is generally low due to poor aqueous solubility (practically insoluble in water), large molecular weight, and extensive first-pass metabolism. In the gut, dioscin is partially hydrolyzed by intestinal microflora to its aglycone diosgenin and intermediate prosapogenins (e.g., trillin, gracillin), which may contribute to bioactivity. Absolute oral bioavailability in rodent models has been estimated at approximately 0.2–5%, though formulation strategies (nanoparticles, solid dispersions) have been explored to improve absorption. • **Key bioactive metabolites:** Diosgenin (aglycone; MW ~414.62 g/mol) is the principal active metabolite and serves as an important precursor in the pharmaceutical synthesis of steroidal hormones (progesterone, cortisone). • **Macronutrients/Micronutrients:** Dioscin itself contributes no significant macronutrients (protein, fat, carbohydrates, fiber), vitamins, or minerals. It is exclusively valued as a bioactive compound. • **Typical experimental dosages in preclinical studies:** 20–80 mg/kg body weight (oral, in rodent models); in vitro IC₅₀ values for cytotoxicity in cancer cell lines generally range from ~1–20 µM. • **Stability notes:** Dioscin is relatively stable under acidic conditions but can undergo hydrolysis of sugar moieties under strongly acidic or enzymatic conditions. It is soluble in methanol, ethanol, DMSO, and slightly soluble in acetone, but practically insoluble in water (<0.01 mg/mL).
Preparation & Dosage
No specific human dosage for pure dioscin is reported. In preclinical trials, a maximal safe dose of 300 mg/kg/day was established in rats. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Diosgenin, Smilax china extract, Tribulus terrestris, Dioscorea nipponica, Dioscorea zingiberensis
Safety & Interactions
Dioscin appears well-tolerated based on traditional use patterns, but comprehensive safety data from controlled studies is lacking. The compound may interact with P-glycoprotein substrates and could potentially affect drug metabolism. Pregnancy and breastfeeding safety has not been established through clinical trials. Individuals taking anticoagulant medications should exercise caution due to potential cardiovascular effects.